http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2949545-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07babb10935f9d76d8479c4e512c7e23 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-055 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4468 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-593 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-004 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-59 |
filingDate | 2015-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8aeedfa0a1f4215768a8d71cf209dd01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f52517ae97dc2e259afaf804f78aa979 |
publicationDate | 2015-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CA-2949545-A1 |
titleOfInvention | Methods of treating and preventing vascular instability diseases |
abstract | Methods are disclosed for treating and preventing vascular instability diseases, such as cerebral cavernous malformation, by the administration of tempol, cholecalciferol, derivatives thereof, pharmaceutically-acceptable salts thereof, or combinations thereof. Methods are disclosed for reducing the number of cerebral cavernous malformation (CCM) lesions in a patient having, or at risk of developing, at least one CCM lesion. Methods are disclosed for reducing the growth rate of the number of cerebral cavernous malformation (CCM) lesions in a patient having, or at risk of developing, at least one CCM lesion. Method are disclosed for preventing or treating a sign or symptom of cerebral cavernous malformation (CCM) in a patient with at least one CCM lesion. Methods are disclosed for decreasing cerebrovascular inflammation, reducing cerebrovascular permeability, or both, in a patient having, or at risk of developing, a cerebral cavernous malformation (CCM) lesion. Methods are disclosed for improving cerebrovascular health in a patient having, or at risk of developing, a cerebral cavernous malformation (CCM) lesion. |
priorityDate | 2014-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 47.